Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06096246 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF)

Study acronym: ORBICA-AF
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Lead sponsor: Barts & The London NHS Trust to Barts & The London NHS Trust Show 4 more changesShow less
    • Primary endpoints: details revised at 1 of 2 entries
    • Eligibility criteria shortened, about 8 words
    • Secondary endpoints: details revised at 7 of 15 entries
    • Publications: details revised at 7 of 7 entries
  2. Re-verified, no change to tracked fieldsv7
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Primary completion date: Aug 5, 2027 to Jul 26, 2027
    • Start date changed from estimate of Aug 5, 2024 to Jul 26, 2024
    v6
  4. Start date: Apr 5, 2024 to Aug 5, 2024v5 Show 4 more changesShow less
    • Primary endpoints: 4 to 2
    • Primary completion date: Apr 5, 2027 to Aug 5, 2027
    • Study completion date: Sep 5, 2027 to Dec 5, 2027
    • Secondary endpoints: 14 to 15
  5. Start date: Jan 5, 2024 to Apr 5, 2024
    • Primary completion date: Jan 5, 2027 to Apr 5, 2027
    • Study completion date: Jun 5, 2027 to Sep 5, 2027
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Secondary endpoints: 13 to 14v3
  2. Study description expanded, about 53 wordsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The main aim of the research is to investigate whether patients undergoing pulmonary vein isolation with catheter ablation for persistent atrial fibrillation (AF) will have lower rates of AF recurrence than those treated by DC cardioversion without an ablation procedure.
Trial Details
NCT Number NCT06096246
Lead Sponsor Barts & The London NHS Trust
Conditions
(from sponsor)		 Persistent Atrial Fibrillation, Cardiac Arrhythmia, Catheter Ablation
Related terms Arrhythmias, Cardiac, Atrial Fibrillation
Enrollment 208 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov